Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model

References

• JemalASiegelRWardECancer statistics, 2006CA Cancer J. Clinic200656106130
   PubMed Web of Science ®Google Scholar
• KanwarJRRoyKKanwarRKColon cancer genetics, nanotherapy and individualized chemotherapyZhouSSneedKBWhelanGPathakYVClinical and translational pharmacogenomicsBoca Raton, FloridaCRC Press2014
   Google Scholar
• AlteriDCSurvivin, cancer networks and pathway-directed drug discoveryNat Rev Cancer200881617018075512
   PubMed Web of Science ®Google Scholar
• KanwarJRKamalapuramSKKanwarRKSurvivin signaling in clinical oncology: a multifaceted dragonMed Res Rev201333476578922688671
   PubMed Web of Science ®Google Scholar
• KonnoRYamakawaHUtsunomiyaHItoKSatoSYajimaAExpression of survivin and Bcl-2 in the normal human endometriumMol Hum Reprod20006652953410825370
   PubMed Web of Science ®Google Scholar
• LiFAmbrosiniGChuEYControl of apoptosis and mitotic spindle checkpoint by survivinNature199839667115805849859993
   PubMed Web of Science ®Google Scholar
• AltieriDCMarchisioCSurviving apoptosis: an interloper between cell death and cell proliferationLab Invest199979111327133310576203
   PubMed Web of Science ®Google Scholar
• VerdeciaMAHuangHDutilEKaiserDAHunterTNoelJPStructure of the human anti-apoptotic protein survivin reveals a dimeric arrangementNat Struct Biol20007760260810876248
   PubMedGoogle Scholar
• SongZYaoXWuMDirect interaction between smac/DIABLO is essential for anti-apoptotic activity of survivin during taxol-induced apoptosisJ Biol Chem200327825231302314012660240
   PubMed Web of Science ®Google Scholar
• TammIWangYSausvilleEIAP family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), bax, caspases, and anti-cancer drugsCancer Res19985823531553209850056
   PubMed Web of Science ®Google Scholar
• KimPJPlesicaJCleversHFeaaronERAltieriDCSurvivin and molecular pathogenesis of colorectal cancerLancet2003362937920520912885482
   PubMed Web of Science ®Google Scholar
• FieldsACCotsonisGSextonDSantoianniRCohenCSurvivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcomeMod Pathol200417111378138515195112
   PubMed Web of Science ®Google Scholar
• GrossmanDKimPJSchechnerJSAltieriDCInhibition of melanoma tumor growth in vivo by survivin targetingProc Natl Acad Sci USA200198263564011149963
   PubMed Web of Science ®Google Scholar
• ZhangMLathamDEDelaneyMAChakravartiASurvivin mediates resistance to antiandrogen therapy in prostate cancerOncogene200524152474248215735703
   PubMed Web of Science ®Google Scholar
• VegranFBoidotRBonnetainFCadouotMChevrierSLizaed-NacolSApoptosis gene signature of survivin and its splice variant expression in breast carcinomaEndocr Relat Cancer201118678379221878572
   PubMed Web of Science ®Google Scholar
• LiguangZPeishuLHongluaMSurvivin expression in ovarian cancerExp Oncol200729212112517704744
   PubMedGoogle Scholar
• OlieRASimões-WüstPSBaumannBA novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapyCancer Res200060112805280910850418
   PubMed Web of Science ®Google Scholar
• LeeMAParkGSLeeHJSurvivin expression and its clinical significance in pancreatic cancerBMC cancer2005512716202147
   PubMed Web of Science ®Google Scholar
• ShankarSLManiSO’GuinKNKandimallaERAgrawalSShafit-ZagardoBSSurvivin inhibition induces human neuronal tumor cell death through caspase-independent and -dependent pathwaysJ Neurochem200179242643611677271
   PubMed Web of Science ®Google Scholar
• KanwarJRKamalapuramSKKanwarRKTargeting survivin in cancer: the cell-signalling perspectiveDrug Discov Today20111611–1248549421511051
   PubMed Web of Science ®Google Scholar
• KanwarRKCheungCHChangJYKanwarJRRecent advances in anti-survivin treatments for cancerCurr Med Chem201017151509151520166933
   PubMed Web of Science ®Google Scholar
• KanwarJRKamalapuramSKKanwarRKTargeting survivin in cancer: patent reviewExpert Opin Ther Pat201020121723173721083520
   PubMed Web of Science ®Google Scholar
• KanwarJRShenWPKanwarRKBergRWKrissansenGWEffects of survivin antagonists on growth of established tumors and B7-1 immunogene therapyJ Natl Cancer Inst200193201541155211604477
   PubMedGoogle Scholar
• BaratchiSKanwarRKCheungCHKanwarJRProliferative and protective effects of SurR9-c84A on differentiated neural cellsJ Neuroimmunol20102271–212013220709413
   PubMed Web of Science ®Google Scholar
• CheungCHASunXKanwarJRBaiJZChengLKrissansenGWA cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapyCancer Cell Int2010103611120142996
   PubMedGoogle Scholar
• SriramojuBKanwarRKKanwarJRNanoformulated cell-penetrating survivin mutant and its dual actionsInt J Nanomedicine201493279329825045261
   PubMed Web of Science ®Google Scholar
• Ravi KumarMNA review of chitin and chitosan applicationsReact Funct Polymers2000461127
   Web of Science ®Google Scholar
• PangburnSHTresconyPVHellerJLysozyme degradation of partially deacetylated chitin, its films and hydrogelsBiomaterials1982321051087082736
   PubMed Web of Science ®Google Scholar
• MiFLShyuSSWongTBJangSFLeeSTLuKTChitosan–polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. II. Effect of pH-dependant ionic crosslinking or interpolymer complex using tripolyphosphate or polyphosphate as reagentJ Appl Poly Sci199974510931107
   Web of Science ®Google Scholar
• ArturssonPLindmarkTDavisSSIllumLEffect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)Pharm Res1994119135813617816770
   PubMed Web of Science ®Google Scholar
• SchipperNGVârumKMStenbergPOcklindGLennernäsHArturssonPChitosan as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus as absorption enhancementEur J Pharm Sci19998433534310425384
   PubMed Web of Science ®Google Scholar
• KanwarJRKanwarRKGut health immunomodulatory and anti-inflammatory functions of gut enzyme digested high protein micro-nutrient dietary supplement-EnprocalBMC Immunol200910711919134173
   PubMedGoogle Scholar
• ZhaoJTenevTMartinsLMDownwardJLemoineNRThe ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent mannerJ Cell Sci2000113Pt 234363437111069780
   PubMed Web of Science ®Google Scholar
• BowmanKLeongKWChitosan nanoparticles for oral drug and gene deliveryInt J Nanomedicine20061211712817722528
   PubMed Web of Science ®Google Scholar
• BhumkarDRJoshiHMSastryMPokharkarVBChitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulinPharm Res20072481415142617380266
   PubMed Web of Science ®Google Scholar
• BhumkarDRPokharkarVBStudies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical noteAAPS Pharm Sci Tech200672138143
   PubMed Web of Science ®Google Scholar
• WuYYangWWangCHuJFuSChitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinateInt J Pharmaceutics20052951235245
   Web of Science ®Google Scholar
• JiJHaoSWuDHuangRXuYPreparation, characterization and in vitro release of chitosan nanoparticles loaded with gentamicin and salicylic acidCarbohydrate Polym201185803808
   Web of Science ®Google Scholar
• KoteraYFontenotJDPecherGMetzgarRSFinnOJHumoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patientsCancer Res19945411285628607514493
   PubMed Web of Science ®Google Scholar
• Van BreemenRBLiYCaco-2 cell permeability assays to measure drug absorptionExpert Opin Drug Metab Toxicol20051217518516922635
   PubMedGoogle Scholar
• LueßenHLRentelCOKotzéAFMucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitroJ Contr Rel19974511523
   Web of Science ®Google Scholar
• WangQChenZDiaoXHuangSInduction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cellsCancer Lett20113021293621220185
   PubMed Web of Science ®Google Scholar
• RocaHVarsosZPientaKJCCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulationJ Biol Chem200828336250572507318611860
   PubMed Web of Science ®Google Scholar
• WalczakHKrammerPHThe CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systemsExp Cell Res20002561586610739652
   PubMed Web of Science ®Google Scholar